Breast Cancer

Breast Cancer
By [http://ezinearticles.com/?expert=Steve_Valentino]Steve Valentino

Breast cancer is a cancer that affects the breast tissue. The primary victims of this type of cancer are females. Statistics show that approximately one out of 11 to 12 women of the Western world are affected by breast cancer. Medical researches have tried aggressively to find a solution to detect the problem earlier or to treat the problem. About 20 percent of the women affected by still fall prey to it and eventually die. In fact, ranks second in cancer deaths for women.

Most starts in the cells that line up the ducts. There are occasions where the cancer cells originate from the lobules, and then spread to other tissues.

Many diagnosis starts in the checking of lumps I the breast. Although most cases of lumps are benign, meaning they are not cancerous, but doctors often ask a patient to undergo biopsy to make sure that cells are not malignant. Most of the lumps are caused by cysts. These lumps may cause pain and swelling of the breast accompanied at times by clear or cloudy discharge in the nipple which happens before the menstrual cycle period is about to begin in a woman. The symptoms may lead to the person

Estrogen for Triple Negative Breast Cancer
<b>Condition</b>:   Female Breast Cancer<br/><b>Intervention</b>:   Drug: Estradiol<br/><b>Sponsor</b>:   University of Wisconsin, Madison<br/><b>Recruiting</b> - verified March 2010
Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer
<b>Conditions</b>:   Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer<br/><b>Interventions</b>:   Drug: vorinostat;   Drug: ixabepilone<br/><b>Sponsor</b>:   City of Hope Medical Center<br/><b>Not yet recruiting</b> - verified March 2010
Female Cancer Patients' Preference For Sexual Health Interventions
<b>Conditions</b>:   Breast Cancer;   Gynecologic Cancer<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Memorial Sloan-Kettering Cancer Center<br/><b>Recruiting</b> - verified March 2010
Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
<b>Condition</b>:   Breast Cancer<br/><b>Interventions</b>:   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Procedure: adjuvant therapy;   Radiation: 3-dimensional conformal accelerated partial breast irradiation<br/><b>Sponsors</b>:   Radiation Therapy Oncology Group;   National Cancer Institute (NCI)<br/><b>Not yet recruiting</b> - verified March 2010
Study of XL147 or XL765 in Combination With Letrozole in Subjects With Breast Cancer
<b>Condition</b>:   Breast Cancer<br/><b>Interventions</b>:   Drug: XL147;   Drug: XL765;   Drug: letrozole (Femara)<br/><b>Sponsor</b>:   Exelixis<br/><b>Not yet recruiting</b> - verified March 2010
Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence
<b>Condition</b>:   Breast Cancer<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   AstraZeneca<br/><b>Not yet recruiting</b> - verified March 2010
89Zr-trastuzumab PET for Imaging the Effect of HSP90 Inhibition
<b>Condition</b>:   Breast Cancer<br/><b>Intervention</b>:   Other: Imaging with 89Zr-trastuzumab PET<br/><b>Sponsor</b>:   University Medical Centre Groningen<br/><b>Recruiting</b> - verified February 2010
Evaluating the Age Extension of the NHS Breast Screening Programme
<b>Condition</b>:   Breast Cancer Mortality<br/><b>Intervention</b>:   Other: Invitation for breast screening<br/><b>Sponsors</b>:   University of Oxford;   Department of Health, United Kingdom<br/><b>Not yet recruiting</b> - verified March 2010
Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab PET
<b>Condition</b>:   Breast Cancer<br/><b>Intervention</b>:   Other: 89Zr-bevacizumab PET imaging<br/><b>Sponsor</b>:   University Medical Centre Groningen<br/><b>Recruiting</b> - verified February 2010
The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer
<b>Condition</b>:   Breast Cancer<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   University of Pittsburgh;   National Center for Research Resources (NCRR)<br/><b>Recruiting</b> - verified March 2010
A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer
<b>Condition</b>:   Neutropenia in Breast Cancer<br/><b>Interventions</b>:   Drug: Filgrastim (Eurofarma);   Drug: Filgrastim (Granulokine, Amgen)<br/><b>Sponsor</b>:   Eurofarma Laboratorios Ltda<br/><b>Not yet recruiting</b> - verified March 2010
Letrozole in Treating Healthy Postmenopausal Women at High Risk for Breast Cancer
<b>Condition</b>:   Breast Cancer<br/><b>Intervention</b>:   Drug: letrozole<br/><b>Sponsors</b>:   University of Arizona;   National Cancer Institute (NCI)<br/><b>Not yet recruiting</b> - verified February 2010
Brain Metastasis in Breast Cancer Patients
<b>Condition</b>:   Breast Cancer<br/><b>Intervention</b>:   Drug: Trastuzumab or Lapatinib<br/><b>Sponsor</b>:   GlaxoSmithKline<br/><b>Active, not recruiting</b> - verified February 2010
Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 Polymorphisms
<b>Conditions</b>:   Breast Cancer;   CYP2D6 Polymorphism<br/><b>Intervention</b>:   Drug: Tamoxifen<br/><b>Sponsor</b>:   Sydney West Area Health Service<br/><b>Not yet recruiting</b> - verified February 2010
Prevention of Capsular Contracture Using Trental and Vitamin E
<b>Condition</b>:   Capsular Contractures<br/><b>Intervention</b>:   Drug: Trental<br/><b>Sponsor</b>:   Legacy Health System<br/><b>Recruiting</b> - verified March 2010
Lymph Fluid and Blood Collection for Identification of Novel Biomarkers
<b>Condition</b>:   Adenocarcinoma of the Breast<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Indiana University<br/><b>Not yet recruiting</b> - verified February 2010
Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats
<b>Conditions</b>:   Ovarian;   Breast;   Prostate;   Pancreatic;   Advanced Tumours<br/><b>Intervention</b>:   Drug: olaparib<br/><b>Sponsor</b>:   AstraZeneca<br/><b>Recruiting</b> - verified March 2010
Carcinogenicity Study of Bupropion
<b>Conditions</b>:   Depressive Disorder;   Cancer<br/><b>Interventions</b>:   Drug: Regular bupropion use;   Drug: Regular SSRI (Selective serotonin reuptake inhibitors) use;   Drug: Regular use of any other antidepressant;   Drug: Regular TCA (Tricyclic antidepressants) use<br/><b>Sponsor</b>:   GlaxoSmithKline<br/><b>Active, not recruiting</b> - verified February 2010
Pilot Pharmacokinetic Study of Daily Versus Monthly High-Dose Cholecalciferol Supplementation
<b>Condition</b>:   Healthy Volunteers<br/><b>Interventions</b>:   Dietary Supplement: Single High Dose Cholecalciferol;   Dietary Supplement: Daily Dose Cholecalciferol<br/><b>Sponsor</b>:   Mayo Clinic<br/><b>Recruiting</b> - verified March 2010

to seek a medical check-up.

Male Victims

Breast cancer is not limited to women though; male victims are present as well. The breast of both male and female have identical tissues, so a man is also prone to acquiring the cancer. It is believed that females are more prone to men because the breast of a woman constantly goes through growth changing hormones, thus the cells are more exposed to cancerous change.

Breast Cancer Awareness

As more and more people fall ill to breast cancer, the month of October has been deemed as month, to commemorate those who passed away from the cancer, the family and friends survived by the deceased. A pink ribbon is the symbol that a person is joining in the commemoration. [http://www.i-BreastCancer.com]Breast Cancer provides detailed information on Breast Cancer, Treatments, Symptoms, Cause Of and more. is affiliated with [http://www.e-Lymphoma.com]Hodgkins Lymphoma.

Article Source: http://EzineArticles.com/?expert=Steve_Valentino http://EzineArticles.com/?Breast-Cancer&id=273509